TBCRC053-M-59105
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Merck Sharp & Dohme
Start Date
May 26, 2022
End Date
May 8, 2027
Administered By
Duke Cancer Institute
Awarded By
Merck Sharp & Dohme
Start Date
May 26, 2022
End Date
May 8, 2027